Casi Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has seven approved drugs.
Drugs and US Patents for Casi Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casi Pharms Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077310-001 | Nov 8, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Casi Pharms Inc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 076280-002 | Jun 27, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Casi Pharms Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077517-002 | Jun 25, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Casi Pharms Inc | ENTECAVIR | entecavir | TABLET;ORAL | 206672-002 | May 11, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Casi Pharms Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077517-001 | Jun 25, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.